Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells
- PMID: 2254014
- PMCID: PMC313746
- DOI: 10.1128/iai.58.12.3856-3862.1990
Immune suppression induced by Actinobacillus actinomycetemcomitans: effects on immunoglobulin production by human B cells
Abstract
Actinobacillus actinomycetemcomitans produces an immunosuppressive factor (ISF) which has been shown to suppress mitogen- and antigen-induced DNA, RNA, and protein synthesis in human T lymphocytes. In this study, we examined purified A. actinomycetemcomitans ISF for its ability to alter immunoglobulin production by human B cells. The ISF caused a dose-dependent inhibition of pokeweed mitogen (PWM)-induced immunoglobulin G (IgG) and IgM production. Preexposure to ISF was not required to achieve maximal inhibition of immunoglobulin synthesis, as previously observed for its effect on T-cell activation. Nevertheless, the ISF appeared to act by irreversibly affecting the early stages of cell activation. While PWM-induced immunoglobulin production is under the influence of T-regulatory circuits, it appears that the ISF interacts directly with B cells. First, ISF failed to alter either the synthesis of interleukin-2 (IL-2) or the expression of IL-2 receptors on T cells. Second, experiments in which individual purified populations of cells were exposed to ISF, washed, and placed back into tissue culture indicated that when all cells (i.e., T cells, B cells, and monocytes) were exposed to ISF, significant suppression was observed. However, when only one cell population was treated with ISF, suppression of both IgG and IgM synthesis was observed only when the B-cell-enriched population was exposed to ISF. These results in conjunction with our earlier findings suggest that the ISF functions via the activation of a regulatory subpopulation of B lymphocytes, which in turn either directly or indirectly (via suppressor T cells) downregulate both B- and T-cell responsiveness. Furthermore, it is hypothesized that patients who harbor A. actinomycetemcomitans could suffer from local or systemic immune suppression. This suppression may enhance the pathogenicity of A. actinomycetemcomitans itself or that of some other opportunistic organism.
Similar articles
-
Adoptive transfer of suppressor T cells induced by Actinobacillus actinomycetemcomitans regulates immune response.J Periodontal Res. 1994 Jan;29(1):1-8. doi: 10.1111/j.1600-0765.1994.tb01084.x. J Periodontal Res. 1994. PMID: 8113948
-
Role of T cell subset on the immunosuppression induced by Actinobacillus actinomycetemcomitans.J Oral Sci. 1999 Sep;41(3):105-10. doi: 10.2334/josnusd.41.105. J Oral Sci. 1999. PMID: 10692834
-
Immunosuppressive properties of Actinobacillus actinomycetemcomitans leukotoxin.Infect Immun. 1988 Jan;56(1):122-7. doi: 10.1128/iai.56.1.122-127.1988. Infect Immun. 1988. PMID: 3335399 Free PMC article.
-
B lymphocyte function in patients with rheumatoid arthritis: impact of regulatory T lymphocytes and macrophages--modulation by antirheumatic drugs.Dan Med Bull. 1988 Apr;35(2):140-57. Dan Med Bull. 1988. PMID: 3282810 Review.
-
[Regulation of immunoglobulin production: role of the cellular receptors for the Fc portion of these molecules].Ann Immunol (Paris). 1982 Sep-Oct;133D(2):199-210. Ann Immunol (Paris). 1982. PMID: 6219609 Review. French.
Cited by
-
Immunosuppressive factor from Actinobacillus actinomycetemcomitans down regulates cytokine production.Infect Immun. 1996 Jan;64(1):50-4. doi: 10.1128/iai.64.1.50-54.1996. Infect Immun. 1996. PMID: 8557373 Free PMC article.
-
Activation of invariant NK T cells in periodontitis lesions.J Immunol. 2013 Mar 1;190(5):2282-91. doi: 10.4049/jimmunol.1201215. Epub 2013 Jan 30. J Immunol. 2013. PMID: 23365081 Free PMC article.
-
Fusobacterium nucleatum inhibits human T-cell activation by arresting cells in the mid-G1 phase of the cell cycle.Infect Immun. 1995 Dec;63(12):4830-6. doi: 10.1128/iai.63.12.4830-4836.1995. Infect Immun. 1995. PMID: 7591143 Free PMC article.
-
The cell cycle-specific growth-inhibitory factor produced by Actinobacillus actinomycetemcomitans is a cytolethal distending toxin.Infect Immun. 1998 Oct;66(10):5008-19. doi: 10.1128/IAI.66.10.5008-5019.1998. Infect Immun. 1998. PMID: 9746611 Free PMC article.
-
Identification of a cytolethal distending toxin gene locus and features of a virulence-associated region in Actinobacillus actinomycetemcomitans.Infect Immun. 1999 Mar;67(3):1227-37. doi: 10.1128/IAI.67.3.1227-1237.1999. Infect Immun. 1999. PMID: 10024565 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources